336 related articles for article (PubMed ID: 32766265)
1. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
Marceau F; Rivard GE; Gauthier JM; Binkley KE; Bonnefoy A; Boccon-Gibod I; Bouillet L; Picard M; Levesque G; Elfassy HL; Bachelard H; Hébert J; Bork K
Front Med (Lausanne); 2020; 7():358. PubMed ID: 32766265
[TBL] [Abstract][Full Text] [Related]
2. Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Charest-Morin X; Hébert J; Rivard GÉ; Bonnefoy A; Wagner E; Marceau F
Front Immunol; 2018; 9():2183. PubMed ID: 30333824
[TBL] [Abstract][Full Text] [Related]
3. Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors.
Marceau F; Bachelard H; Rivard GÉ; Hébert J
BMC Res Notes; 2019 May; 12(1):291. PubMed ID: 31133046
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Modeling of Bradykinin-Mediated Angioedema States.
Marceau F; Bachelard H; Charest-Morin X; Hébert J; Rivard GE
Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32824891
[TBL] [Abstract][Full Text] [Related]
5. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
6. Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin.
Hintze S; Möhl BS; Beyerl J; Wulff K; Wieser A; Bork K; Meinke P
Front Physiol; 2022; 13():1090732. PubMed ID: 36685169
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
8. Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency.
Miyata T; Horiuchi T
Allergol Int; 2023 Jul; 72(3):375-384. PubMed ID: 37169642
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
[TBL] [Abstract][Full Text] [Related]
10. Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor.
Bova M; Suffritti C; Bafunno V; Loffredo S; Cordisco G; Del Giacco S; De Pasquale TMA; Firinu D; Margaglione M; Montinaro V; Petraroli A; Radice A; Brussino L; Zanichelli A; Zoli A; Cicardi M
Allergy; 2020 Jun; 75(6):1394-1403. PubMed ID: 31860755
[TBL] [Abstract][Full Text] [Related]
11. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII).
Bork K; Wulff K; Witzke G; Hardt J
Allergy; 2017 Feb; 72(2):320-324. PubMed ID: 27905115
[TBL] [Abstract][Full Text] [Related]
12. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations.
de Maat S; Björkqvist J; Suffritti C; Wiesenekker CP; Nagtegaal W; Koekman A; van Dooremalen S; Pasterkamp G; de Groot PG; Cicardi M; Renné T; Maas C
J Allergy Clin Immunol; 2016 Nov; 138(5):1414-1423.e9. PubMed ID: 27130860
[TBL] [Abstract][Full Text] [Related]
13. Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations.
Bork K; Wulff K; Witzke G; Hardt J
Allergy; 2015 Aug; 70(8):1004-12. PubMed ID: 25952149
[TBL] [Abstract][Full Text] [Related]
14. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
16. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
Grumach AS; Veronez CL; Csuka D; Farkas H
Front Immunol; 2021; 12():785736. PubMed ID: 34956216
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
[TBL] [Abstract][Full Text] [Related]
18. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).
Wedner HJ
Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S14-S17. PubMed ID: 33109319
[TBL] [Abstract][Full Text] [Related]
19. A mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogen.
Dickeson SK; Kumar S; Sun MF; Mohammed BM; Phillips DR; Whisstock JC; Quek AJ; Feener EP; Law RHP; Gailani D
Blood; 2022 May; 139(18):2816-2829. PubMed ID: 35100351
[TBL] [Abstract][Full Text] [Related]
20. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
